 |
|
|
|
|
|
|
|
 |
Results for 'Billion Dollar Pharmaceuticals Club - JP' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Billion Dollar Pharmaceuticals Club - Europe
Profiles of the Leading Europe Players
|
September 2000 |
£99 |
100 % |
The World OTC Pharmaceutical Market Analysis & Forecasts, 2008-2023
|
June 2008 |
£1499 |
33.25 % |
Pharmaceutical Anti-Counterfeiting Strategies
Protecting profits through operational security, new technologies and industry partnerships
|
January 2005 |
£1495 |
27.5 % |
The Pharmaceutical Industry
Key events and trends shaping its current status and future direction
|
March 2006 |
£3690 |
27.3 % |
Amgen
Profile, Patents and Pipeline
|
August 2005 |
£335 |
26.95 % |
Amgen: Profile, Patents and Pipeline
Profile, Patents and Pipeline
|
August 2005 |
£335 |
26.95 % |
Pain Therapeutics 2005
Market Dynamics and Outlook
|
May 2005 |
£1340 |
22 % |
Advanced Drug Delivery Systems: New Developments, New Technologies
|
October 2006 |
£3255 |
21 % |
Biotech 2010
|
June 2006 |
£3255 |
20.5 % |
The Outlook for Pharmaceuticals in Latin America
|
March 2007 |
£1995 |
20 % |
Multiple Sclerosis World Market Outlook to 2011
|
June 2007 |
£2010 |
19.5 % |
Anti-Infectives
World Market, 2nd. Ed., Vol. I
|
March 2007 |
£2010 |
19.5 % |
Generic Drug Market in Canada
|
February 2008 |
£940 |
19 % |
The Outlook for Pharmaceuticals in Northern Europe
|
March 2007 |
£1995 |
18.5 % |
The Pharmaceutical Market: Egypt
|
February 2006 |
£595 |
18.5 % |
Cancer Diagnostic Testing World Markets
|
April 2008 |
£2280 |
18.5 % |
Global Pharmaceutical Market Forecast to 2012
|
October 2008 |
£655 |
17 % |
Therapeutics for Inflammatory Diseases
Current Challenges and Future Market
|
March 2006 |
£3255 |
17 % |
Nanomaterials
Markets by Type
|
December 2005 |
£3045 |
16.1 % |
Female Sexual Dysfunction
Prescription Drug Pipeline Overview 2007
|
July 2007 |
£2000 |
15.5 % |
Product Relaunch Excellence: Transforming Lackluster Pharmaceutical Products into Market Success Stories
|
October 2004 |
£3120 |
15 % |
Winning Product Launch Strategies
Maximizing sales from new pharmaceutical products
|
April 2007 |
£1495 |
14.7 % |
Major Milestones: Female Sexual Dysfunction
|
August 2005 |
£3000 |
14.5 % |
Online Pharmaceutical Industry, 2006-2011, The
|
July 2006 |
£1499 |
14 % |
Life Science Tools and Technologies for Bio-Pharma R&D
Instruments, Tech Platforms, Informatics and Market
|
March 2003 |
£1005 |
14 % |
U.S. Next Generation Bio-Tools for Accelerating Bio-Pharmaceutical Drug Discovery R&D
Technologies, Opportunities and Market
|
March 2001 |
£1400 |
13.65 % |
Vaccines
The World Market
|
February 2007 |
£2680 |
13.5 % |
Vaccines: The World Market
|
February 2007 |
£2680 |
13.5 % |
Nanomedicine 2006-2011
|
June 2006 |
£1499 |
12.5 % |
Insulin Delivery Systems Market Analysis
(2007-2010)
|
February 2008 |
£940 |
12.5 % |
C-MAP Canadian Drug Benefit Plans Reference Guide 2006 Edition
|
January 2006 |
£2195 |
12 % |
World market for cancer vaccines 2007-2012
|
January 2007 |
£1999 |
11.5 % |
U.S. Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications, The
|
July 2005 |
£2010 |
11.2 % |
U.S. Market for Over-the-Counter Pediatric Medication and Healthcare Products
|
March 2006 |
£2010 |
11.2 % |
GSK's Cervarix
A Future Blockbuster of 2007
|
March 2007 |
£1999 |
11 % |
Forecast Insight: Multiple Sclerosis
Tysabri to prevail despite safety setbacks
|
August 2008 |
£7600 |
9.45 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
9.1 % |
In-Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
9.1 % |
|
|
|
|
